Suchergebnisse - "Church, Kevin J"

PubPharm (16)

1

Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2024

von Reda, S. | Setti, S. | Berthiaume, A. | +6

2

ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS

enthalten in: Frontiers in neuroscience | 2024

von Berthiaume, A. | Reda, S. | Kleist, K. | +7

3

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2023

von Johnston, J. | Reda, S. | Setti, S. | +6

4

The Case for a Novel Therapeutic Approach to Dementia : Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators

enthalten in: Journal of Alzheimer's disease : JAD | 2023

von Moebius, H. | Church, K.

5

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia

enthalten in: Neurotherapeutics | 2022

von Johnston, J. | Reda, S. | Setti, S. | +6

6

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia

enthalten in: Neurotherapeutics | 2022

von Johnston, J. | Reda, S. | Setti, S. | +6

7

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia

enthalten in: NeuroRX | 2022

von Johnston, J. | Reda, S. | Setti, S. | +6

8

Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development : Utility of the P300 Event-Related Potential

enthalten in: Neural plasticity | 2022

von Olichney, J. | Xia, J. | Church, K. | +1

9

Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma

enthalten in: Cytokine | 2019

von Vanderwerff, B. | Church, K. | Kawas, L. | +1

10

Hepatocyte Growth Factor and Macrophage-stimulating Protein "Hinge" Analogs to Treat Pancreatic Cancer

enthalten in: Current cancer drug targets | 2019

von Wright, J. | Church, K. | Harding, J.